ROC curve analysis showed that the risk model constructed by the expression and prognosis of IFIT2 and METTL3 in esophageal cancer patients was closely related to the prognosis survival of more than 3 years (AUC = 0.77) (Figure 9C). Here, METTL3 is linked to esophageal cancer.